World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01184222
Date of registration: 19/07/2010
Primary sponsor: Centre Hospitalier Universitaire de Nice
Public title: Efficacy Evaluation Of Great Occipital Nerve Electrical Stimulation On Rebound Headache
Scientific title: EFFICACY EVALUATION OF GREAT OCCIPITAL NERVE ELECTRICAL STIMULATION ON REBOUND HEADACHE AFTER WITHDRAWAL IN MEDICATION OVERUSE HEADACHE OCCURING IN MIGRAINE PATIENTS (SENGO-CAM Study)
Date of first enrolment: November 2010
Target sample size: 30
Recruitment status: Recruiting
URL:  http://clinicaltrials.gov/show/NCT01184222
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment  
Countries of recruitment
France
Contacts
Name:   CAILLON Cynthia
Address: 
Telephone:
Email: giran.c@chu-nice.fr
Affiliation: 
Name:   LANTERI-MINET Michet, PhD
Address: 
Telephone:
Email:
Affiliation:  Neurosurgery department
Name:   FONTAINE Denys, PhD
Address: 
Telephone:
Email:
Affiliation:  Neurosurgery depatment - CHU Pasteur, Nice
Key inclusion & exclusion criteria

Inclusion Criteria:

- age > 18 years old

- migraine patient with medication overuse headache by non specific analgesics
according to the ICHD-II diagnostic criteria

- failure of outpatient withdrawal

- Signature of informed consent.

- Affiliation to French national health and pensions organization

Exclusion Criteria:

- pregnancy (positive pregnancy test at pre-study) and breast-feeding

- patients with medication overuse headache by specific antimigraine treatment
(triptans or/and ergot derivatives) according to the ICHD-II diagnostic criteria

- previous surgical treatment targeting great occipital nerves



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
HEADACHE
Intervention(s)
Device: great occipital nerve stimulation
Primary Outcome(s)
Primary endpoint will be the comparison of the rate of headache-free patients, fourteen days after medication withdrawal, in both groups (GONS versus sham) [Time Frame: 14 days]
Secondary Outcome(s)
maximal intensity and duration of rebound headache [Time Frame: 14 days]
number of headache days during the 14 days withdrawal period [Time Frame: 14 days]
rescue medication used [Time Frame: 14 days]
withdrawal facility perceived by the patient [Time Frame: 14 days]
Secondary ID(s)
02-API-07
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history